You are here Home Guidance and resources Resources International scientific guidelines adopted in Australia International scientific guideline: Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture EMA/CHMP/BWP/368186/2011 adopted by the Therapeutic Goods Administration (TGA) Listen Print Share LinkedIn (Twitter) Facebook Email Loading... About this guideline Overseas effective date: 24 Feb 2014 Categories: Biological medicines | Drug substance | Vaccines (drug substance) Access this international scientific guideline TGA annotations Effective 1 November 2014: the Quality aspects of this Guideline are replaced by EMA/CHMP/BWP/310834/2012 Guideline on Influenza Vaccines - Quality Module. The nonclinical and clinical aspects of this Guidelines continue to apply. Further information: In place of concept paper EMEA/CHMP/BWP/481473/2008 For more information see International scientific guidelines adopted in Australia. Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.